retatrutide ly3437943 glp-1 gip glucagon receptor agonist LY3437943, a novel triple glucagon, GIP, and for glycemic control and weight loss: From discovery to clinical proof of concept 🧬 R3TA is a next-generation

As a registered dietitian who's spent the past decade researching supplements, weight loss programs and emerging health trends, I wanted to find out

10.1016/0014-4886(82)90047-4 Exp

AstraZeneca Key Development Products Elecoglipron Formerly AZD5004, ECC5004 Oral small-molecule GLP-1 receptor agonist Current Positioning AstraZeneca is developing elecoglipron, a candidate compound for which it acquired rights outside of China from the Chinese company Eccogene

Becaria A, Campbell A, Bondy SC

Avoid sugar consumption: Limiting refined sugars intake helps protect collagen and elastin from damage, keeping the skin firmer and slowing premature aging

Similarly, brain energy metabolism and functions ranging from development to synaptic plasticity to axonal integrity are also dependent on lactate transport primarily between glia and neurons